United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$13Mraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Mass Medical Angels
MBL PartnersReported by FinSMEs
From a historical funding recordSEC filing: $1.0M sold, first sale Aug 2015
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Mass Medical AngelsBoehringer IngelheimMBL Partners
Portage BiotechBioInnovation Capital/ ChiesiMissing a round, or an investor who was in one? Tell us.
Sentien Biotechnologies's investors include Boehringer Ingelheim Venture Fund, Mass Medical Angels, Boehringer Ingelheim, MBL Partners and Portage Biotech, and 1 more on record.
Sentien Biotechnologies has raised $13M across 2 rounds since 2015.
Sentien Biotechnologies's most recent round was a Series A of $12M in Apr 2017.
Its most recent round, $12M in Apr 2017, is also its largest on record.
Sentien Biotechnologies's first round on record, in Aug 2015, was backed by Boehringer Ingelheim Venture Fund and Portage Biotech.
Sentien Biotechnologies's latest named round is a Series A, in Apr 2017.
Sentien Biotechnologies is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
